ABSTRACT
Nontyphoidal Salmonella (NTS) is one of the most prevalent bacterial causes of gastrointestinal infections worldwide. Meanwhile, the detection rate of CTX-M-55 ESBL-positive has increased gradually in China. To identify the molecular epidemiological and genomic characteristics of blaCTX-M-55-carrying nontyphoidal Salmonella (NTS) clinical isolates, a total of 105 NTS isolates were collected from a Chinese tertiary hospital. Antimicrobial susceptibility testing was performed to determine the resistance phenotype. Whole-genome sequencing and bioinformatics analysis were used to determine the antimicrobial resistance genes, serotypes, phylogenetic relationships, and the genetic environment of the blaCTX-M-55 gene. The results showed that among the 22 ceftriaxone resistant isolates, the blaCTX-M-55 was the most common β-Lactamase gene carried by 14 isolates, including serotypes S. Typhimurium (10/14), S. Muenster (2/14), S. Rissen (1/14), and S. Saintpaul (1/14). Phylogenetic analysis shows that 10 blaCTX-M-55-positive S. Typhimurium ST34 isolates were divided into two clusters. The genetic relationship of isolates in each cluster was very close (≤10 cgMLST loci). The blaCTX-M-55 gene was located on the chromosome in 10 isolates, on IncI1 plasmid in three isolates, and IncHI2 plasmid in one isolate. In conclusion, the blaCTX-M-55 gene, mainly located on the chromosome of S. Typhimurium ST34 isolates, was the main driving force associated with the resistance of NTS to cephalosporins. Therefore, close attention to the clonal dissemination of blaCTX-M-55-carrying S. Typhimurium ST34 in clinical settings must be monitored carefully.
IMPORTANCE ESCs are the first choice for treating NTS infections. However, ESBLs and AmpC β-lactamases are the most typical cause for ESCs resistance. The CTX-M-55 ESBL-positive rate has gradually increased in the clinic in recent years. At present, the research about blaCTX-M-55-positive Salmonella mainly focuses on the foodborne animals or the environment while less on clinical patients. Thus, this study was carried out for identifying molecular epidemiological and genomic characteristics of blaCTX-M-55-carrying NTS clinical isolates. The results showed that the blaCTX-M-55 gene, mainly located on the chromosome of S. Typhimurium ST34 isolates from Conghua District, was the main driving force associated with the resistance of NTS to cephalosporins. Therefore, our work highlights the importance of monitoring the clonal dissemination of blaCTX-M-55-carrying S. Typhimurium ST34 in clinical settings.
KEYWORDS: S. Typhimurium ST34, CTX-M-55, IncHI2, chromosome, cephalosporins
INTRODUCTION
Nontyphoidal Salmonella (NTS) consists of more than 2600 serotypes and is one of the most prevalent bacterial causes of gastrointestinal diseases worldwide (1). In the Global Burden of Disease Study 2010 of the Institute for Health Metrics and Evaluation, enteric NTS was estimated to cause 4.8 million disability-adjusted life years and 81,300 deaths (2, 3). NTS serotypes are diverse in their host range and epidemiology while varying in their propensity to cause severe human diseases (4). The most widely reported serotypes associated with gastrointestinal diseases across China are S. Typhimurium and S. Enteritidis (5). In the United States, S. Enteritidis is the most common serotype associated with human foodborne diseases, followed by S. Typhimurium, S. Newport, S. Heidelberg, and S. Montevideo (6). Though most cases of human NTS diarrheal are self-limiting and usually do not require treatment. However, antibiotic treatment is necessary when invasive infection occurs, besides for children and elderly patients (7, 8). Ampicillin, trimethoprim-sulfamethoxazole, and chloramphenicol are the preferred first-line therapeutic antimicrobial agents recommended in the clinic (9). With the emergence and rapid development of resistance phenotype ACSSuT (defined as resistance to ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, and tetracycline) in the early 1980s in Salmonella, fluoroquinolones (FQs) and extended spectrum cephalosporins (ESCs) have been used widely to treat NTS infection (4, 9–12).
ESCs are the first choice for treating NTS infections because FQs use contraindication in children (5). Therefore, the development of NTS isolates resistant to ESCs, such as ceftriaxone, represents a substantial public health concern (4). Generally, the productions of extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases are the most typical causes for ESCs resistance (13). Since the first report of Escherichia coli CTX-M ESBLs in 1989, the CTX-M family has spread worldwide and became the most prevalent ESBLs (14, 15). The CTX-M-15 and CTX-M-14 are the most common variants detected in clinical pathogens all over the world, followed by CTX-M-2, CTX-M-3 and CTX-M-1 (16). Previous data suggest that ESCs resistance genes in Salmonella were mainly blaCMY-2 and blaCTX-M-15 (4, 13, 17–19). A study conducted in Thailand (20) found that the blaCTX-M-55 was the vital ESCs resistance mechanism for S. Cholerae in NTS from 2012 to 2016. CTX-M-55 is a variant of CTX-M-15, which possesses similar hydrolysis activities to ESCs. However, enhanced activity of CTX-M-55 was found for ceftazidime (15). CTX-M-55 was first found in E. coli in Thailand in 2005 (15) and first detected in Salmonella in China in 2011 (21). Recently, the detection rate of CTX-M-55 identified in ESBLs E. coli has increased gradually worldwide, especially in China, irrespective of the clinic, livestock industry, and environment (22–29). In several studies (16, 23, 30), the detection rate of CTX-M-55 in E. coli has exceeded the rate of CTX-M-15, becoming the second prevalent ESBLs in China. The incidence rate of CTX-M-55-producing bacteria has increased significantly in both animals and humans (22, 31). Available data suggest that the blaCTX-M-55 gene is located on the epidemic plasmids, such as IncF, IncI1, IncHI2, and IncA/C carried by Salmonella (25, 31–33). To date, many researchers have focused on CTX-M-55-producing E. coli, whereas only a few studies have focused on the CTX-M-55-producing Salmonella, especially isolates isolated from clinical patients.
Clinically, the detection rate of Salmonella increases sharply in June and July each year in our hospital. Notably, some NTS isolates were resistant to ESCs. Therefore, the objective of this study was to analyze the prevalence and antimicrobial resistance mechanisms of cephalosporins in NTS isolates obtained from a tertiary hospital in China.
RESULTS
Bacterial strains.
From May 21, 2020, to February 22, 2021, 105 NTS isolates were isolated from patients in a Chinese tertiary hospital. The number of NTS isolates collected in different months is shown in Fig. 1. The highest detection rate of NTS was in July, accounting for 30.48% (32/105). The detection rate from December to February was relatively low, accounting for only 8.57% (9/105). Among the 105 patients, there were 56 males and 49 females, with a male to female ratio of 1.14:1. The isolation sources include stool (95.24%, 100/105), blood (2.86%, 3/105), purulent secretion (0.95%, 1/105) and urine (0.95%, 1/105). The age of patients ranged from 14 days to 83 years, of which 61.90% were ≤ 1 year old, 15.24% were 2–5 years old, 5.71% were 6–17 years old, 11.43% were 18–59 years old, and 5.71% were ≥ 60 years old. A total of 14 blaCTX-M-55-positive isolates (Table S2) were detected in 105 NTS. Among these, the patient’s age ranged from 2 months to 83 years, of which 57.14% (8/14) were ≤1 year old. All blaCTX-M-55-positive isolates were derived from the stool sample. Of note, 50% of blaCTX-M-55-positive strains were isolated in July (Table S2).
FIG 1.

The trend of the incidences of NTS isolates.
Serotype.
A total of 13 serotypes were identified among the 105 NTS isolates (Fig. 2). Among these isolates, S. Typhimurium was the most prevalent serotype (66.67%, 70/105), followed by S. Enteritidis (8.57%, 9/105), S. London (6.67%, 7/105), S. Rissen (4.76%, 5/105), and S. Stanley (3.81%, 4/105). Collectively, these serotypes accounted for 90.48% (95/105) of NTS isolates in the present study. Additionally, among 70 isolates of S. Typhimurium, 56 were ST34, and 14 were ST19.The serotypes of blaCTX-M-55-positive isolates consisted of S. Typhimurium ST34 (10/14), S. Muenster ST321 (2/14), S. Rissen ST469 (1/14), and S. Saintpaul ST27 (1/14).
FIG 2.
The serotype distribution of the NTS isolates.
Phylogenetic analysis of blaCTX-M-55-carrying isolates.
In the ceftriaxone resistant isolates (n = 22), 14 carried the blaCTX-M-55 gene (Table S2). Among them, β-lactamase genes blaTEM-1 (5/14) and blaLAP-2 (1/14) were also detected. Meanwhile, the β-lactamase coding genes, including blaCTX-M-65, blaCTX-M-123, blaTEM-1, blaCMY-2, blaOXA-1, and blaOXA-10, were detected in the 8 ceftriaxone resistant isolates (Table S2). The CTX-M type was the most abundant β-Lactamases, accounting for 86.36% (19/22). On the other hand, the detection rate of blaCTX-M-55 gene was 63.64% (14/22), which was the most common ESBLs.
The minimum spanning tree (MST) based on the cgMLST allele profile of blaCTX-M-55-positive S. Typhimurium ST34 isolates showed that it could be divided into two clusters. The genetic relationship of isolates in each cluster was closely related (≤10 alleles) (Fig. S1). Interestingly, these strains were isolated from the stool sample of patients living in different streets. Four strains of cluster 1 were isolated in July, and the other four strains of cluster 1 were from June, August, September, and November, respectively (Table S2). The two strains of cluster 2 were isolated from patients of different ages and different departments of hospitalization. The results indicated that the S. Typhimurium ST34 strain carrying the blaCTX-M-55 gene has a clonal epidemic trend in this district, likely to be part of an uncovered outbreak epidemic event. Moreover, cgMLST analysis revealed only five allele differences between the two S. Muenster strains (Fig. S2). The whole-genome sequence of 22 S. Typhimurium ST34, 19 S. Rissen ST469, 2 S. Muenster ST321, and 1 S. Saintpaul ST27 isolates recovered from China were downloaded from EnteroBase (https://enterobase.warwick.ac.uk/species/index/senterica, retrieved in February 2022). The strain metadata was listed in Table S3. The phylogenetic analysis revealed that our blaCTX-M-55-positive S. Typhimurium ST34 isolates differed by the 137~220 SNPs with other Chinese S. Typhimurium ST34 isolates deposited in the public database (Fig. 3B). In this study, the number of SNP differences in the 56 strains of S. Typhimurium ST34 ranged from 2 to 160 (Fig. S3). In addition, the resistance genes carried by the blaCTX-M-55-positive S. Typhimurium ST34 were not enriched by other Chinese S. Typhimurium ST34.
FIG 3.
Phylogeny and the distribution of antimicrobial resistance genes of blaCTX-M-55-positive isolates from the present study and NTS isolates from China contained from the EnteroBase database. (A) Systematic analysis of blaCTX-M-55-positive isolates in this study and NTS isolates from China contained in the EnteroBase database. (B) SNP difference range and resistance gene distribution among strains of various serotypes. The strains from this study were marked with purple stars. Different colored boxes represent the resistance genes for the different types of antibiotics, while the blank boxes indicate the resistance genes which were not detected.
Antibiotic susceptibility and resistance genes detection.
Among all the isolates, 86.7% were resistant to AMP, followed by CHL (40%) and SXT (39%) (Table S4). Interestingly, the resistance rates of NTS isolate to CRO, CAZ and FEP were 21%, 18.1%, and 13.3%, respectively. Meanwhile, the sensitivity of NTS isolates for CIP reduced, in which the resistance rate was only 3.8%, with the intermediary rate of 56.2%. All isolates were susceptible to IPM and LVX, while most isolates (94.3%) presented a high susceptible rate to AZM. Genomic data revealed that (i) all AMP resistant strains carried at least one ESBLs or AmpC gene (including blaTEM, blaCTX-M, blaOXA, blaLAP, and blaCMY); (ii) 92.7% (38/41) of CHL resistant strains carried at least one gene responsible for phenicol resistance (including floR, cmlA, and cat); (iii) all SXT resistant strains carried at least one gene that causing co-trimoxazole resistance (including dfrA and sul); (iv) 77.8% of CIP insensitive strains carried at least one of the genes of aac(6′)-Ib-cr, oqxA, oqxB, qepA8, qnrB, qnrS1, and qnrS2; (v) and all AZM resistant strains carried mph(A) gene which mediates macrolide resistance.
All of the blaCTX-M-55-positive isolates were resistant to the CXM, CRO, CAZ, and AMP but unsusceptible to FEP, as the resistance rate of FEP was 78.6% (Table S5). The sensitivity of blaCTX-M-55-positive isolate for CIP was also decreased, with an intermediate rate of 78.6%. Additionally, the resistance rates of blaCTX-M-55-positive isolates for CHL and SXT were 21.4%, while the resistance rate to AZM was only 7.1%. However, all blaCTX-M-55-positive isolates were sensitive to IPM and LVX. The 10 blaCTX-M-55-positive isolates were S. Typhimurium ST34, out of which the resistance phenotype of 7 isolates was “AMP+CXM+CAZ+CRO+FEP”, and the remaining 3 isolates were “AMP+CXM+CAZ+CRO” (Table 1). The resistance phenotype of the two S. Muenster isolates carrying blaCTX-M-55 gene was “AMP+CXM+CAZ+CRO+FEP+CHL”. Thus, blaCTX-M-55 gene mediates the high level of FEP resistance. Furthermore, compared with S. Typhimurium ST34, the clinical treatment of the other three serotypes carrying blaCTX-M-55 gene was more challenging. Meanwhile, the number of resistance genes carried by blaCTX-M-55-positive isolates with serotypes S. Muenster, S. Rissen, and S. Saintpaul were significantly higher than those in S. Typhimurium ST34 (Table 1). For example, cmlA1 and floR genes were not detected in S. Typhimurium ST34 but the other three serotypes. Of note, 11 (78.57%) of blaCTX-M-55-positive isolates also carried the qnrS gene mediating FQs resistance, of which all isolates had lesser sensitivity to CIP (Table 1). Importantly, in this study, the two S. Muenster strains only carried one plasmid of ColRNAI, as most of the resistance genes were carried on their chromosome.
TABLE 1.
The genomic characteristics of blaCTX-M-55-carrying isolates
| Isolates | Serotype | ST | Location of blaCTX-M-55 | Plasmids | Resistance phenotype | Resistance genesa |
|---|---|---|---|---|---|---|
| S25b | Saintpaul | 27 | IncHI2 | IncHI2 | AMP+CXM+CAZ+CRO+FEP+CHL+AZM | blaCTX-M-55, qnrS, blaLAP-2, blaTEM-1, aph(3′)-Ia, aph(6)-Id, arr-2, dfrA14, floR, mph(A),tet(A) |
| S102 | Rissen | 469 | IncI1 | IncI1, Col440II, ColRNAI | AMP+CXM+CAZ+CRO+FEP+SXT | blaCTX-M-55, blaTEM-1, aadA1, aadA2, dfrA12, sul3, tet(A) |
| S29b | Typhimurium | 34 | IncI1 | IncI1, IncQ1,Col440II, Col8282, ColRNAI | AMP+CXM+CAZ+CRO+FEP | blaCTX-M-55, blaTEM-1, aph(3′')-Ib, aph(6)-Id, sul2,tet(B) |
| S33 | Typhimurium | 34 | IncI1 | IncI1, IncQ1,Col156, Col440II, Col8282, ColRNAI | AMP+CXM+CAZ+CRO+FEP | blaCTX-M-55, blaTEM-1, aph(3′')-Ib, aph(6)-Id, sul2, tet(B) |
| S24 | Typhimurium | 34 | Chromosome | ColRNAI | AMP+CXM+CAZ+CRO+FEP | blaCTX-M-55, qnrS, tet(B) |
| S34b | Typhimurium | 34 | Chromosome | \c | AMP+CXM+CAZ+CRO+FEP | blaCTX-M-55, qnrS, tet(B) |
| S36 | Typhimurium | 34 | Chromosome | \ | AMP+CXM+CAZ+CRO+FEP | blaCTX-M-55, qnrS, tet(B) |
| S42 | Typhimurium | 34 | Chromosome | Col440I | AMP+CXM+CAZ+CRO+FEP | blaCTX-M-55, qnrS, tet(B) |
| S92 | Typhimurium | 34 | Chromosome | IncQ1 | AMP+CXM+CAZ+CRO+FEP | blaCTX-M-55, qnrS, blaTEM-1, aph(3′')-Ib, aph(6)-Id, sul2, tet(B) |
| S49 | Typhimurium | 34 | Chromosome | \ | AMP+CXM+CAZ+CRO | blaCTX-M-55, qnrS, tet(B) |
| S79 | Typhimurium | 34 | Chromosome | \ | AMP+CXM+CAZ+CRO | blaCTX-M-55, qnrS, tet(B) |
| S133 | Typhimurium | 34 | Chromosome | \ | AMP+CXM+CAZ+CRO | blaCTX-M-55, qnrS, tet(B) |
| S69 | Muenster | 321 | Chromosome | ColRNAI | AMP+CXM+CAZ+CRO+FEP+CHL+SXT | blaCTX-M-55, qnrS, aac(3)-IId, aadA22, aph(6)-Id, arr-2, dfrA14, floR, lnu(F), sul3, tet(A) |
| S136 | Muenster | 321 | Chromosome | ColRNAI | AMP+CXM+CAZ+CRO+FEP+CHL+SXT | blaCTX-M-55, qnrS, aac(3)-IId, aadA22, aph(6)-Id, arr-2, dfrA14, floR, lnu(F), sul3, tet(A) |
Underlined genes were located on chromosomes (only sequenced strains on the Nanopore platform were analyzed).
The isolate was selected and sequenced for long read sequencing on Nanopore platform.
\, indicates no plasmid.
The location and genetic environment of blaCTX-M-55 gene.
For most blaCTX-M-55-positive isolates (10/14), the blaCTX-M-55 gene was located on the chromosome. In addition, the blaCTX-M-55 gene of three isolates was situated on the IncI1 plasmid and the gene of one strain was located on the IncHI2 plasmid (Table 1). Therefore, the blaCTX-M-55 gene located on the IncI1 plasmid carried by the two S. Typhimurium ST34 isolates (S29 and S33) could be successfully conjugated into the recipient. Consistent with the original donor strains, the MIC of the two transconjugants for CRO, CAZ, and FEP were ≥ 64mg/L, ≥64 mg/L, and 16 mg/L, respectively (Table S5).
The genetic context of blaCTX-M-55 gene was different on the IncI1 plasmid, IncHI2 plasmid, and the chromosome (Fig. 4). The mobile elements located upstream of blaCTX-M-55 included ISEcp1 (complete or incomplete) and IS26, while the downstream of blaCTX-M-55 gene was a hypothetical protein named ORF477. The genetic structure of the blaCTX-M-55 gene on pS29-IncI1 (CP085700) in isolate S29 was “ISEcp1-blaCTX-M-55-orf477.” Additionally, the qnrS gene was located downstream of blaCTX-M-55 gene on the IncHI2 plasmid and the chromosome of the blaCTX-M-55-positive NTS isolates. The genetic environment of the IncHI2 is similar to that of the chromosome, the main difference being that IS26 is located at both ends of the chromosome, and ISEcp1 is truncated by an IS26. ISEcp1 upstream of the blaCTX-M-55 gene on IncHI2 was complete. (Fig. 4). The search in the NCBI database revealed that the chromosomes of S. Typhimurium (CP061122.1) strain isolated from a patient in Zhejiang, China, and S. Gloucester (MN619286.1) strain isolated from roast duck products in Guangdong, China, also contained this genetic structure “IS26-ΔISEcp1-blaCTX-M-55-orf477-tnpA-IS3-qnrS-IS26.” Importantly, the IS26 composite transposon seems to play an essential role in the emergence and transmission of blaCTX-M-55 between chromosome and IncHI2 plasmid.
FIG 4.
The genetic environments of blaCTX-M-55-positive isolates. Different colored arrows indicate different open reading frames (ORFs), while the direction of the arrow indicates its transcription direction. Light gray shadows represent homologous areas. The isolates from the current study were identified in blue. ISEcp1 located on the chromosome of isolate S34 was disrupted by IS26, while ISEcp1 in pS29-IncI1 and pS25-IncHI2 plasmid were complete.
Interestingly, the sequence similarity of IncI1 plasmid pS29-IncI1and pEC32-IncI1 (CP085621) was up to 99.94% by BLAST (Fig. 5), carrying only one resistance gene blaCTX-M-55. In our previous study, pEC32-IncI1 was the vital plasmid carrying blaCTX-M-55 gene found in E. coli isolate EC32. When searching the NCBI GenBank database, we found the sequence identity between the several IncI1 plasmids carrying blaCTX-M-55 gene isolated from E. coli (pWP3-S18-ESBL-09, AP022037.1), Klebsiella pneumonia (pKP4823_3, CP082793.1), and S. Typhimurium (pST53-2, CP050747.1) was higher than 99% (Fig. 5). In our previous study, the pEC71-IncHI2 (CP085623) plasmid carrying the blaCTX-M-55 gene was found in the E. coli, which was mainly had a similar structure of IncHI2 plasmid pS25-IncHI2 (CP085697) isolated from S. Saintpaul isolate S25 in this study by BLAST (Fig. 6). Interestingly, the fragment carrying the blaCTX-M-55 gene (about 19000 bp) between the two IncHI2 plasmids pS25-IncHI2 and pEC71-IncHI2 had a reverse orientation, which also contains qnrS and dfrA14 genes. In addition, the blaCTX-M-55 gene flanking sequence contained in the two IncHI2 plasmids was the same. However, compared with pS25-IncHI2, pEC71-IncHI2 lacked one IS26 transposon in the reverse fragment (Fig. 6).
FIG 5.
The circle diagram of IncI1 plasmid carrying blaCTX-M-55 gene in Salmonella isolate S29 and E. coli isolate EC32. The inner circle is GC content, the second circle is GC skew, the third circle to the seventh circle are different IncI1 plasmid, and the outermost circle represents the annotation. The reference sequence used was pS29-IncI1. The sequence identity between the fiveIncI1 plasmids was higher than 99%. The position of the “ISEcp1-blaCTX-M-55-orf477” genetic structure is marked in black.
FIG 6.
The gene fragment containing blaCTX-M-55 on the IncHI2 plasmid. The light gray shadow indicates the homologous region, and the blue box shows the gene fragment containing the blaCTX-M-55 gene. The blaCTX-M-55 gene fragment contained in plasmid pS25-IncHI2 of Salmonella isolate S25 and plasmid pEC71-IncHI2 of E. coli isolate EC71 are similar IS26 added upstream of ISEcp1 of pEC71-IncHI2 (indicated by red dotted box).
DISCUSSION
NTS infection is an important public health concern. Ours and previous data suggest that NTS infection frequently occurs in summer, and the risk groups are infants, the elderly, and males (34–36). It may be due to the warm weather and concentrated rainfall in summer, suitable for NTS reproduction, and easily polluting food (35, 36). Consumption of contaminated food or water is the main route of NTS transmission (37).
S. Typhimurium has a variety of hosts and is one of the most common serotypes for foodborne illnesses in humans and animals (38). Many studies have revealed S. Typhimurium as the most common serotype in China in the pediatric and adult population (5, 39). In this study, 13 serotypes were identified in the 105 NTS isolates. Among them, S. Typhimurium was the most common serotype, accounting for almost 66.67% of all the isolates, much higher than the second-largest serotype S. Enteritidis (8.57%). More than 60 STs were found in S. Typhimurium worldwide, out of which ST34 (57%) and ST19 (28.4%) were the most common STs in Asia alone (40). In this study, only two STs were found in S. Typhimurium, of which 80% were ST34, and 20% were ST19. This study indicates that S. Typhimurium was the leading serotype in the district, where ST34 was the main clone.
After the severe resistance from NTS, FQs and ESCs were extensively used to treat the NTS infection (9–11). While Salmonella infection tends to occur more in children, the FQs are contraindicated in this age group. Therefore, ESCs remain the primary treatment of choice for NTS in children. Notably, a high level of resistance to ESCs has been reported, usually related to the plasmid-mediated transmission of AmpC or ESBLs genes (11). Among the ceftriaxone-resistant isolates collected in this study, the blaCTX-M-55 gene had the highest detection rate. The Salmonella isolated from foodborne infection in the animals in Guangzhou, China (24). The blaCTX-M-55 gene was also the most common ESBLs gene. In addition, the blaCTX-M-55 gene was still the major ESBLs in the analysis of S. Typhimurium from patients with diarrhea in Shanghai, China (41). Likewise, similar reports have been reported from Cambodia and Thailand (20, 25).
Different NTS serotypes are evident for host predilection (42). Most of the blaCTX-M-55-positive isolates in this study were S. Typhimurium ST34 (10/14). However, it was previously reported (24) that the most common serotype of the blaCTX-M-55 gene of Salmonella in Chinese foodborne animals was S. Indian (7/12). The S. Typhimurium ST34 has attracted international attention due to its rapid transmission and multiple drug resistance (MDR). Moreover, previous studies showed that although S. Typhimurium ST34 showed rapid expansion in China, it was sensitive to ESCs (43). However, the blaCTX-M-55 gene in S. Typhimurium caused a high resistance level for the ESCs in this study. As an effective choice for the treatment of NTS infection, the current resistance situation of ESCs is not optimistic. Surprisingly, the phylogenetic analysis of blaCTX-M-55-positive S. Typhimurium isolates indicated the S. Typhimurium ST34 strain with blaCTX-M-55 gene on the chromosome has a clonal epidemic trend in this district. Other serotypes carrying the blaCTX-M-55 gene were also detected in the study, although in a relatively smaller number. S. Muenster is often seen in cattle and has rare in humans (44, 45). In most cases, the S. Muenster was often associated with fatality rates (46, 47). Our study showed that the two S. Muenster strains were closely related and carried multiple resistance genes on the chromosomes. This observation may highlight the associated significant challenges to clinical treatment. However, because the numbers of S. Muenster were relatively small in this study, it is difficult to interpret whether it is an epidemic clone. The MDR of S. Saintpaul S25 in this study might be mediated by the plasmid pS25-IncHI2, which carries many antimicrobial resistance genes. Furthermore, the blaLAP-2 gene, with the narrow hydrolysis spectrum against β-lactams inhibited by clavulanic acid (48), was also detected in isolate S25. Meanwhile, isolates S25 carried the mph(A) gene, which might have a high resistance to azithromycin (49). However, azithromycin gained the approval of the US Food and Drug Administration (FDA) in 2011 as an additional drug for treating Salmonella infection (50). The emergence of the mph(A) gene in NTS also brings corresponding challenges to public health. S. Rissen is a common serotype distributed in the swineherds, pork, and chicken products, most of which are MDR strains, having a strong ability to infect humans (51, 52). With the emergence of multidrug resistant NTS, public health faces significant challenges. Therefore, NTS isolates carrying the blaCTX-M-55 gene should be critically monitored.
The conjugative plasmid is an important factor for the emergence and transmission of resistance genes. A study in Cambodia (25) showed that the transmission of S. Enteritidis of the blaCTX-M-55 gene was mediated by IncA/C2 (14/26) and IncHI2 (10/26) plasmids. However, the study on blaCTX-M-55 on Salmonella for foodborne infection of animals in Guangzhou (24) showed that 1 of 11 isolates was located on the IncHI2 plasmid. Among the blaCTX-M-55-positive isolates in this study, in addition to chromosome and IncHI2 plasmid, the blaCTX-M-55 gene of three isolates was located on IncI1 plasmid. Our previous reports have shown that the IncI1 plasmid was a predominant plasmid carrying blaCTX-M-55 gene in E. coli in this district, while most of them can be transferred by conjugation experiment. We also found that the sequence of IncI1 plasmid carrying blaCTX-M-55 gene in Salmonella and E. coli was almost similar (99.94%), whereas they both carried only one resistance geneblaCTX-M-55. IncI1 plasmid was one of the most common plasmids carrying the blaCTX-M-55 gene in E. coli (26). In this study, the IncI1 plasmid located in the two S. Typhimurium ST34 strains could be transferred through a conjugation experiment, indicating that the IncI1 plasmid might play a vital role in transmitting the blaCTX-M-55 gene in Enterobacteriaceae. A study (53) on the surveillance of antibiotic resistance plasmids in Salmonella isolates showed that the IncHI2 was the main plasmid lineage, helping spread antibiotic resistance in Salmonella. The plasmid pS25-IncHI2 carried multiple resistance genes in this study, including blaCTX-M-55, blaTEM, qnrS, dfrA14, and tet(A). Interestingly, pS25-IncHI2 could not be transferred through the conjugation experiment; however its role in the MDR of clinical Salmonella isolates should not be underestimated.
Generally, the genes responsible for cephalosporin resistance of clinical isolates are mainly associated with the plasmids (11). However, the frequency of the blaCTX-M-55 gene of NTS isolates on chromosomes was much higher than that of plasmids in this study. We found the high frequency (10/14) of the blaCTX-M-55 gene on the NTS chromosome. Among them, 8 strains with the blaCTX-M-55 gene located on the chromosome were S. Typhimurium ST34, and all belong to cluster 1 by cgMLST analysis (differential allele ≤10). Of note, most blaCTX-M-55-carrying isolates also harbored the qnrS gene, which can mediate low-level FQs resistance. Although PMQR genes only confer low-level FQs resistance, their presence (especially qnrS) provides strains with selective advantages under FQs exposure. It can also accelerate the development of chromosome-mediated drug resistance (24, 54). Though the high frequency of the blaCTX-M-55 gene on the chromosomes has been reported previously in Guangzhou (11/12), the isolation source was from foodborne animals, and the most frequent serotype was S. Indian (7/11), followed by S. Typhimurium (2/10) (24). Unfortunately, the above study lacks the analysis of the blaCTX-M-55 genetic environment on the chromosome. Furthermore, the strains of cluster 1 came from different patients, coming from different subdistrict, and the dates of isolates collection were also different (Table S2). The phylogenetic tree also showed that the blaCTX-M-55-positive S. Typhimurium ST34 isolated from the Conghua district had large SNP different from other Chinese S. Typhimurium ST34 (Fig. 3). These results suggest that the S. Typhimurium ST34 strain carrying blaCTX-M-55 gene has a clonal epidemic trend in this district or was likely to be an outbreak epidemic event. Considering the relatively few strains in this study, we will continue to collect clinical isolates for follow-up research. Some studies speculate that the cross-species transmission of the blaCTX-M-55 gene from a plasmid in E. coli to the Salmonella chromosome was conducive to the transmission and stability of the blaCTX-M-55 gene in Salmonella (24, 55). Therefore, close observation is required for the clonal dissemination of blaCTX-M-55-chromosomally located S. Typhimurium ST34 in clinical settings.
By analyzing the genetic environment of blaCTX-M-55 on IncHI2 and chromosome, we found that the genetic environment of blaCTX-M-55 gene on IncHI2 and chromosome is almost the same (about 6500 bp); the difference is that there is an IS26 composite transposon in the genetic environment of chromosome “IS26-ΔISEcp1-blaCTX-M-55-orf477-tnpA-IS3-qnrS-IS26.” It is worth mentioning that the gene environment of 10 strains of blaCTX-M-55 gene on the chromosome was consistent, including S. Muenster isolates. Interestingly, the above composite transposons were also detected on the chromosomes of S. Gloucester strain (32) isolated from Guangdong roast duck products in China and S. Typhimurium strain of a patient in Zhejiang, China. Furthermore, it is reported (56–59) that IS26 plays a significant role in the movement, expression and transmission of antibiotic resistance genes (ARGs) in Gram-negative bacteria (especially Enterobacteriaceae). This strain can mediate the transfer of resistance genes through various transposition modes. The most common transposition mode is the intermolecular transposition of the composite transposon (16). The composite transposon consists of two copies of IS26. Therefore, we speculated that the transposon event mediated by IS26 composite transposon might be an important event for transferring blaCTX-M-55 gene from IncHI2 plasmid to chromosome and its occurrence on the chromosomes of different serotypes of Salmonella. Combining the two IS26 elements can form a composite transposon, which may mediate the reversal of the blaCTX-M-55 gene fragment on pEC71-IncHI2and pS25-IncHI2. A study (56) reported various ARGs and multiple IS26 copy regions on the composite transposon bounded by IS26. Overall, IS26 composite transposon-mediated transposition plays a vital role in transferring the blaCTX-M-55 gene of NTS.
Conclusion.
S. Typhimurium ST34 is the primary pathogen of NTS infection in a Chinese tertiary hospital. The blaCTX-M-55 gene was the most common β-Lactamase gene in the NTS and was mainly located on the chromosome. Notably, the S. Typhimurium ST34 strain with blaCTX-M-55 gene on the chromosome has a clonal epidemic trend in the studied period. Furthermore, IncI1 plasmid, IncHI2 plasmid, and IS26 composite transposon-mediated transposition also play an essential role in transferring the blaCTX-M-55 gene in Salmonella. Meanwhile, the blaCTX-M-55 and qnrS gene cotransfer warrants additional attention because it may accelerate the development and spread of isolates coresistant to cephalosporins and fluoroquinolones. Most importantly, close attention needs to be paid to monitor the clonal dissemination of blaCTX-M-55-carrying S. Typhimurium in clinical settings.
MATERIALS AND METHODS
Bacterial strains.
From May 21, 2020, to February 22, 2021, 105 NTS nonrepetitive strains were isolated from different patients in the Fifth Affiliated Hospital of Southern Medical University, China. The isolates were identified by Vitek-2 COMPACT automatic microbial identification system (bioMérieux, Marcy-l'Étoile, France). E. coli ATCC 25922 was used as the quality control strain.
Antimicrobial susceptibility testing.
MICs for ESBLs-resistant phenotype were determined using the Vitek-2 Automated Susceptibility System (60). The MICs of NTS isolates for amoxicillin-clavulanic acid (AMC), sulfamethoxazole (SXT), cefuroxime (CXM), ceftriaxone (CRO), ceftazidime (CAZ),cefepime (FEP), cefoxitin (FOX), imipenem (IPM), and levofloxacin (LVX) were determined by broth microdilution. The susceptibility of NTS isolates for azithromycin (AZM), ampicillin (AMP), ciprofloxacin (CIP), and chloramphenicol (CHL) was determined by the Kirby Bauer disk diffusion method. The interpretation of the results was made based on the Clinical and Laboratory Standards Institute (CLSI/NCCLSM100-S30) (61).
Whole-genome sequencing and bioinformatics analysis.
The genomic DNA of 105 NTS isolates was extracted by the bacterial genomic DNA extraction kit (Tiangen, Beijing, China) and then sequenced using Illumina NovaSeq 6000 platform (Novogene, Tianjin, China). The quality of the raw sequence reads was checked by the interactive program FastQC (62), assembled by SPAdes 3.13.1 (63), and annotated by Prokka 1.14.5 (64). The serotypes of NTS were analyzed using SISTR 1.1.1 (65) and the sequence type (ST) was analyzed by multilocus sequence typing (MLST 2.18.0) (66). The antimicrobial resistance genes and plasmids replicon type were determined based on the CGE server (67). CGE's ResFinder 4.1 and PlasmidFinder 2.1 web tools with default threshold settings for minimum % identity 90% and minimum % coverage 60% were used for analyses. The blaCTX-M-55-positive NTS were selected for subsequent analysis. The core genome multilocus sequence typing (cgMLST) of 10 blaCTX-M-55-positive S. Typhimurium isolates was performed using Ridom SeqSphere+ 4.1.9 (68). Three representative blaCTX-M-55-positive S. Typhimurium isolates were selected and sequenced on the Oxford Nanopore platform (Novogene, Tianjin, China), which blaCTX-M-55 gene was located on the chromosome, IncI1 plasmid, and IncHI2 plasmid, respectively (Details of selection is shown in the Table S1). The hybrid genome assembly using both long and short reads was performed by Unicycler 0.4.8 (69). A phylogenetic tree was constructed using Parsnp (70) and was edited with MEGA X (71). Finally, the location and genetic environment of the blaCTX-M-55 gene in blaCTX-M-55-positive NTS were analyzed and illustrated with BRIG (72). The genetic context of the blaCTX-M-55 gene was drawn by Easyfig (73).
Plasmid conjugation experiments.
The transferability of the plasmid carrying the blaCTX-M-55 gene was determined by the conjugation experiments with the rifampin-resistant E.coli C600 as the recipient strain. Transconjugants were selected on the Luria-Bertani agar plates containing rifampin (100 μg/mL) and CRO (4 μg/mL). PCR (Primers as follows: CTX-M-55-F is CAGCGCTTTTGCCGTCTAAG, and CTX-M-55-R is GGCCCATGGTTAAAATCACTGC) sequencing was used to verify the transconjugants containing the blaCTX-M-55 gene. In addition, an antimicrobial susceptibility test was performed to confirm the antimicrobial resistance characteristics of these transconjugants.
Nucleotide sequence accession number.
This Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank under the accession ID: JAJGYQ000000000-JAJGZD000000000. The complete nucleotide sequences of plasmids pS25-IncHI2, pS29-IncI1, pEC32-IncI1, and pEC71-IncHI2 have been uploaded to the NCBI GenBank database under accession no. CP085697, CP085700, CP085621, and CP085623, respectively. The complete genomic sequence of isolate S34 that blaCTX-M-55 gene located on the chromosome has been uploaded to NCBI GenBank database with accession no. CP086118.
Supplementary Material
ACKNOWLEDGMENTS
We thank Zhi Ruan (Sir Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China) for his suggestions and revisions to this study, and Yan Jiang (Sir Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China) for his technical assistance in the genomic data analysis.
We declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.
This project was funded by the National Natural Science Foundation for the Youth of China (81902104), the International Cooperation and Exchange Program of the National Natural Science Foundation of China (81861138056), and Guangdong Basic and Applied Basic Research Foundation (2021A1515220153).
Footnotes
Supplemental material is available online only.
Contributor Information
Aiwu Wu, Email: aiwwu66@163.com.
Chao Zhuo, Email: Chao_sheep@263.net.
Xiaoyan Li, Email: xiaoyanli@gzhmu.edu.cn.
Sandeep Tamber, Health Canada.
REFERENCES
- 1.Issenhuth-Jeanjean S, Roggentin P, Mikoleit M, Guibourdenche M, de Pinna E, Nair S, Fields PI, Weill FX. 2014. Supplement 2008–2010 (no. 48) to the White-Kauffmann-Le Minor scheme. Res Microbiol 165:526–530. doi: 10.1016/j.resmic.2014.07.004. [DOI] [PubMed] [Google Scholar]
- 2.Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, et al. 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128. doi: 10.1016/S0140-6736(12)61728-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basanez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabe E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, et al. 2012. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197–2223. doi: 10.1016/S0140-6736(12)61689-4. [DOI] [PubMed] [Google Scholar]
- 4.Crump JA, Sjolund-Karlsson M, Gordon MA, Parry CM. 2015. Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections. Clin Microbiol Rev 28:901–937. doi: 10.1128/CMR.00002-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Liang B, Xie Y, He S, Mai J, Huang Y, Yang L, Zhong H, Deng Q, Yao S, Long Y, Yang Y, Gong S, Zhou Z. 2019. Prevalence, serotypes, and drug resistance of nontyphoidal Salmonella among paediatric patients in a tertiary hospital in Guangzhou, China, 2014–2016. J Infect Public Health 12:252–257. doi: 10.1016/j.jiph.2018.10.012. [DOI] [PubMed] [Google Scholar]
- 6.(CDC) CfDCaP. 2013. Foodborne Outbreak Online Database (FOOD). http://wwwn.cdc.gov/foodborneoutbreaks/Default.aspx.
- 7.Rabsch W, Tschape H, Baumler AJ. 2001. Non-typhoidal salmonellosis: emerging problems. Microbes Infect 3:237–247. doi: 10.1016/s1286-4579(01)01375-2. [DOI] [PubMed] [Google Scholar]
- 8.McDermott PF, Zhao S, Tate H. 2018. Antimicrobial resistance in nontyphoidal Salmonella. Microbiol Spectr 6. doi: 10.1128/microbiolspec.ARBA-0014-2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hohmann EL. 2001. Nontyphoidal salmonellosis. Clin Infect Dis 32:263–269. doi: 10.1086/318457. [DOI] [PubMed] [Google Scholar]
- 10.Ma Y, Li M, Xu X, Fu Y, Xiong Z, Zhang L, Qu X, Zhang H, Wei Y, Zhan Z, Chen Z, Bai J, Liao M, Zhang J. 2018. High-levels of resistance to quinolone and cephalosporin antibiotics in MDR-ACSSuT Salmonella enterica serovar Enteritidis mainly isolated from patients and foods in Shanghai, China. Int J Food Microbiol 286:190–196. doi: 10.1016/j.ijfoodmicro.2018.09.022. [DOI] [PubMed] [Google Scholar]
- 11.Feng Y, Chang YJ, Fang SH, Su LH, Li HC, Yang HP, Yu MJ, Chiu CH. 2019. Emergence and evolution of high-level cephalosporin-resistant Salmonella Goldcoast in Northern Taiwan. Open Forum Infect Dis 6:ofz447. doi: 10.1093/ofid/ofz447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Threlfall EJ. 2002. Antimicrobial drug resistance in Salmonella: problems and perspectives in food- and water-borne infections. FEMS Microbiol Rev 26:141–148. doi: 10.1111/j.1574-6976.2002.tb00606.x. [DOI] [PubMed] [Google Scholar]
- 13.Arlet G, Barrett TJ, Butaye P, Cloeckaert A, Mulvey MR, White DG. 2006. Salmonella resistant to extended-spectrum cephalosporins: prevalence and epidemiology. Microbes Infect 8:1945–1954. doi: 10.1016/j.micinf.2005.12.029. [DOI] [PubMed] [Google Scholar]
- 14.Bauernfeind A, Grimm H, Schweighart S. 1990. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18:294–298. doi: 10.1007/BF01647010. [DOI] [PubMed] [Google Scholar]
- 15.Kiratisin P, Apisarnthanarak A, Saifon P, Laesripa C, Kitphati R, Mundy LM. 2007. The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand. Diagn Microbiol Infect Dis 58:349–355. doi: 10.1016/j.diagmicrobio.2007.02.005. [DOI] [PubMed] [Google Scholar]
- 16.Zhao WH, Hu ZQ. 2013. Epidemiology and genetics of CTX-M extended-spectrum beta-lactamases in Gram-negative bacteria. Crit Rev Microbiol 39:79–101. doi: 10.3109/1040841X.2012.691460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Shigemura H, Matsui M, Sekizuka T, Onozuka D, Noda T, Yamashita A, Kuroda M, Suzuki S, Kimura H, Fujimoto S, Oishi K, Sera N, Inoshima Y, Murakami K. 2018. Decrease in the prevalence of extended-spectrum cephalosporin-resistant Salmonella following cessation of ceftiofur use by the Japanese poultry industry. Int J Food Microbiol 274:45–51. doi: 10.1016/j.ijfoodmicro.2018.03.011. [DOI] [PubMed] [Google Scholar]
- 18.Su LH, Wu TL, Chia JH, Chu C, Kuo AJ, Chiu CH. 2005. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J Antimicrob Chemother 55:846–852. doi: 10.1093/jac/dki116. [DOI] [PubMed] [Google Scholar]
- 19.Na SH, Moon DC, Kang HY, Song HJ, Kim SJ, Choi JH, Yoon JW, Yoon SS, Lim SK. 2020. Molecular characteristics of extended-spectrum beta-lactamase/AmpC-producing Salmonella enterica serovar Virchow isolated from food-producing animals during 2010–2017 in South Korea. Int J Food Microbiol 322:108572. doi: 10.1016/j.ijfoodmicro.2020.108572. [DOI] [PubMed] [Google Scholar]
- 20.Luk-In S, Chatsuwan T, Pulsrikarn C, Bangtrakulnonth A, Rirerm U, Kulwichit W. 2018. High prevalence of ceftriaxone resistance among invasive Salmonella enterica serotype Choleraesuis isolates in Thailand: the emergence and increase of CTX-M-55 in ciprofloxacin-resistant S. Choleraesuis isolates. Int J Med Microbiol 308:447–453. doi: 10.1016/j.ijmm.2018.03.008. [DOI] [PubMed] [Google Scholar]
- 21.Yu F, Chen Q, Yu X, Li Q, Ding B, Yang L, Chen C, Qin Z, Parsons C, Zhang X, Huang J, Luo Y, Wang L, Pan J. 2011. High prevalence of extended-spectrum beta lactamases among Salmonella enterica Typhimurium isolates from pediatric patients with diarrhea in China. PLoS One 6:e16801. doi: 10.1371/journal.pone.0016801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Bevan ER, Jones AM, Hawkey PM. 2017. Global epidemiology of CTX-M beta-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother 72:2145–2155. doi: 10.1093/jac/dkx146. [DOI] [PubMed] [Google Scholar]
- 23.Zhang J, Zheng B, Zhao L, Wei Z, Ji J, Li L, Xiao Y. 2014. Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals. BMC Infect Dis 14:659. doi: 10.1186/s12879-014-0659-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Zhang CZ, Ding XM, Lin XL, Sun RY, Lu YW, Cai RM, Webber MA, Ding HZ, Jiang HX. 2019. The emergence of chromosomally located bla CTX-M-55 in salmonella from foodborne animals in China. Front Microbiol 10:1268. doi: 10.3389/fmicb.2019.01268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Nadimpalli M, Fabre L, Yith V, Sem N, Gouali M, Delarocque-Astagneau E, Sreng N, Le Hello S, group Bs . 2019. CTX-M-55-type ESBL-producing Salmonella enterica are emerging among retail meats in Phnom Penh, Cambodia. J Antimicrob Chemother 74:342–348. doi: 10.1093/jac/dky451. [DOI] [PubMed] [Google Scholar]
- 26.Xia L, Liu Y, Xia S, Kudinha T, Xiao SN, Zhong NS, Ren GS, Zhuo C. 2017. Prevalence of ST1193 clone and IncI1/ST16 plasmid in E-coli isolates carrying blaCTX-M-55 gene from urinary tract infections patients in China. Sci Rep 7:44866. doi: 10.1038/srep44866. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Kim YA, Kim H, Choi MH, Seo YH, Lee H, Lee K. 2020. Whole-genome analysis of blaCTX-M-55-carrying Escherichia coli among pigs, farm environment, and farm workers. Ann Lab Med 40:180–183. doi: 10.3343/alm.2020.40.2.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Sekizuka T, Inamine Y, Segawa T, Kuroda M. 2019. Characterization of NDM-5- and CTX-M-55-coproducing Escherichia coli GSH8M-2 isolated from the effluent of a wastewater treatment plant in Tokyo Bay. Infect Drug Resist 12:2243–2249. doi: 10.2147/IDR.S215273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Chotinantakul K, Woottisin S, Okada S. 2021. The emergence of CTX-M-55 in ESBL-producing Escherichia coli from vegetables sold in local markets of northern Thailand. Jpn J Infect Dis. doi: 10.7883/yoken.JJID.2021.139. [DOI] [PubMed] [Google Scholar]
- 30.Cao X, Cavaco LM, Lv Y, Li Y, Zheng B, Wang P, Hasman H, Liu Y, Aarestrup FM. 2011. Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals. J Clin Microbiol 49:2496–2501. doi: 10.1128/JCM.02503-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Fu Y, Xu X, Zhang L, Xiong Z, Ma Y, Wei Y, Chen Z, Bai J, Liao M, Zhang J. 2020. Fourth generation Cephalosporin resistance among Salmonella enterica Serovar Enteritidis isolates in Shanghai, China conferred by bla CTX-M-55 harboring plasmids. Front Microbiol 11:910. doi: 10.3389/fmicb.2020.00910. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Li L, Olsen RH, Song A, Xiao J, Wang C, Meng H, Shi L. 2021. First report of a foodborne Salmonella enterica Serovar Gloucester (4:i:l,w) ST34 strain harboring bla CTX-M- 55 and qnrS genes located in IS26-mediated composite transposon. Front Microbiol 12:646101. doi: 10.3389/fmicb.2021.646101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Sun RY, Ke BX, Fang LX, Guo WY, Li XP, Yu Y, Zheng SL, Jiang YW, He DM, Sun J, Ke CW, Liu YH, Liao XP. 2020. Global clonal spread of mcr-3-carrying MDR ST34 Salmonella enterica serotype Typhimurium and monophasic 1,4,[5],12:i:- variants from clinical isolates. J Antimicrob Chemother 75:1756–1765. doi: 10.1093/jac/dkaa115. [DOI] [PubMed] [Google Scholar]
- 34.Yang X, Jin K, Yang F, Yuan G, Liu W, Xiang L, Wu Z, Li Z, Mao J, Shen J, Lombe N, Zandamela H, Hazoume L, Hou X, Ding Y, Cao G. 2017. Nontyphoidal Salmonella gastroenteritis in Baoshan, Shanghai, China, 2010 to 2014: an etiological surveillance and case-control study. J Food Prot 80:482–487. doi: 10.4315/0362-028X.JFP-16-309. [DOI] [PubMed] [Google Scholar]
- 35.Zhan Z, Xu X, Gu Z, Meng J, Wufuer X, Wang M, Huang M, Chen J, Jing C, Xiong Z, Zeng M, Liao M, Zhang J. 2019. Molecular epidemiology and antimicrobial resistance of invasive non-typhoidal Salmonella in China, 2007–2016. Infect Drug Resist 12:2885–2897. doi: 10.2147/IDR.S210961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Parisi A, Crump JA, Stafford R, Glass K, Howden BP, Kirk MD. 2019. Increasing incidence of invasive nontyphoidal Salmonella infections in Queensland, Australia, 2007–2016. PLoS Negl Trop Dis 13:e0007187. doi: 10.1371/journal.pntd.0007187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Poetter C, Kunstmann G, Peter D, Mattner F. 2014. Containment of a cheesecake-associated outbreak of salmonellosis in 3 different hospitals, detected by continuous microbiologic surveillance. Am J Infect Control 42:816–817. doi: 10.1016/j.ajic.2014.03.013. [DOI] [PubMed] [Google Scholar]
- 38.Asai T, Esaki H, Kojima A, Ishihara K, Tamura Y, Takahashi T. 2006. Antimicrobial resistance in Salmonella isolates from apparently healthy food-producing animal from 2000 to 2003: the first stage of Japanese veterinary antimicrobial resistance monitoring (JVARM). J Vet Med Sci 68:881–884. doi: 10.1292/jvms.68.881. [DOI] [PubMed] [Google Scholar]
- 39.Deng X, Ran L, Wu S, Ke B, He D, Yang X, Zhang Y, Ke C, Klena JD, Yan M, Feng Z, Kan B, Liu X, Mikoleit M, Varma JK. 2012. Laboratory-based surveillance of non-typhoidal Salmonella infections in Guangdong Province, China. Foodborne Pathog Dis 9:305–312. doi: 10.1089/fpd.2011.1008. [DOI] [PubMed] [Google Scholar]
- 40.Li W, Li Y, Liu Y, Shi X, Jiang M, Lin Y, Qiu Y, Zhang Q, Chen Q, Zhou L, Sun Q, Hu Q. 2017. Clonal expansion of biofilm-forming Salmonella Typhimurium ST34 with multidrug-resistance phenotype in the Southern Coastal Region of China. Front Microbiol 8:2090. doi: 10.3389/fmicb.2017.02090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Wang J, Li Y, Xu X, Liang B, Wu F, Yang X, Ma Q, Yang C, Hu X, Liu H, Li H, Sheng C, Xie J, Du X, Hao R, Qiu S, Song H. 2017. Antimicrobial Resistance of Salmonella enterica Serovar Typhimurium in Shanghai, China. Front Microbiol 8:510. doi: 10.3389/fmicb.2017.00510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Ferrari RG, Rosario DKA, Cunha-Neto A, Mano SB, Figueiredo EES, Conte-Junior CA. 2019. Worldwide epidemiology of Salmonella serovars in animal-based foods: a meta-analysis. Appl Environ Microbiol 85. doi: 10.1128/AEM.00591-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Wong MH, Yan M, Chan EW, Liu LZ, Kan B, Chen S. 2013. Expansion of Salmonella enterica Serovar Typhimurium ST34 clone carrying multiple resistance determinants in China. Antimicrob Agents Chemother 57:4599–4601. doi: 10.1128/AAC.01174-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Oloya J, Doetkott D, Khaitsa ML. 2009. Antimicrobial drug resistance and molecular characterization of Salmonella isolated from domestic animals, humans, and meat products. Foodborne Pathog Dis 6:273–284. doi: 10.1089/fpd.2008.0134. [DOI] [PubMed] [Google Scholar]
- 45.van Cauteren D, Jourdan-da Silva N, Weill FX, King L, Brisabois A, Delmas G, Vaillant V, de Valk H. 2009. Outbreak of Salmonella enterica serotype Muenster infections associated with goat's cheese, France, March 2008. Euro Surveill 14. doi: 10.2807/ese.14.31.19290-en. [DOI] [PubMed] [Google Scholar]
- 46.Jones TF, Ingram LA, Cieslak PR, Vugia DJ, Tobin-D'Angelo M, Hurd S, Medus C, Cronquist A, Angulo FJ. 2008. Salmonellosis outcomes differ substantially by serotype. J Infect Dis 198:109–114. doi: 10.1086/588823. [DOI] [PubMed] [Google Scholar]
- 47.Andino A, Hanning I. 2015. Salmonella enterica: survival, colonization, and virulence differences among serovars. ScientificWorldJournal 2015:520179. doi: 10.1155/2015/520179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Kocsis B, Kocsis E, Fontana R, Cornaglia G, Mazzariol A. 2013. Identification of blaLAP-(2) and qnrS1 genes in the internationally successful Klebsiella pneumoniae ST147 clone. J Med Microbiol 62:269–273. doi: 10.1099/jmm.0.050542-0. [DOI] [PubMed] [Google Scholar]
- 49.Zhang J, Jin H, Hu J, Yuan Z, Shi W, Ran L, Zhao S, Yang X, Meng J, Xu X. 2014. Serovars and antimicrobial resistance of non-typhoidal Salmonella from human patients in Shanghai, China, 2006–2010. Epidemiol Infect 142:826–832. doi: 10.1017/S0950268813001659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Sjolund-Karlsson M, Joyce K, Blickenstaff K, Ball T, Haro J, Medalla FM, Fedorka-Cray P, Zhao S, Crump JA, Whichard JM. 2011. Antimicrobial susceptibility to azithromycin among Salmonella enterica isolates from the United States. Antimicrob Agents Chemother 55:3985–3989. doi: 10.1128/AAC.00590-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Xu X, Biswas S, Gu G, Elbediwi M, Li Y, Yue M. 2020. Characterization of multidrug resistance patterns of emerging Salmonella enterica Serovar Rissen along the food chain in China. Antibiotics (Basel) 9:660. doi: 10.3390/antibiotics9100660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Zhou A, Li J, Xu Z, Ni J, Guo J, Yao YF, Wu W. 2020. Whole-genome comparative and pathogenicity analysis of Salmonella enterica subsp. enterica Serovar Rissen. G3 (Bethesda) 10:2159–2170. doi: 10.1534/g3.120.401201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Chen W, Fang T, Zhou X, Zhang D, Shi X, Shi C. 2016. IncHI2 plasmids are predominant in antibiotic-resistant Salmonella isolates. Front Microbiol 7:1566. doi: 10.3389/fmicb.2016.01566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. 2009. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 22:664–689. doi: 10.1128/CMR.00016-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Wong MH, Liu L, Yan M, Chan EW, Chen S. 2015. Dissemination of IncI2 plasmids that harbor the blaCTX-M element among clinical Salmonella isolates. Antimicrob Agents Chemother 59:5026–5028. doi: 10.1128/AAC.00775-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Harmer CJ, Hall RM. 2015. IS26-mediated precise excision of the IS26-aphA1a translocatable unit. mBio 6:e01866-01815–e01815. doi: 10.1128/mBio.01866-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Garcia V, Garcia P, Rodriguez I, Rodicio R, Rodicio MR. 2016. The role of IS26 in evolution of a derivative of the virulence plasmid of Salmonella enterica serovar Enteritidis which confers multiple drug resistance. Infect Genet Evol 45:246–249. doi: 10.1016/j.meegid.2016.09.008. [DOI] [PubMed] [Google Scholar]
- 58.Lee H, Doak TG, Popodi E, Foster PL, Tang H. 2016. Insertion sequence-caused large-scale rearrangements in the genome of Escherichia coli. Nucleic Acids Res 44:7109–7119. doi: 10.1093/nar/gkw647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Pong CH, Harmer CJ, Ataide SF, Hall RM. 2019. An IS26 variant with enhanced activity. FEMS Microbiol Lett 366. doi: 10.1093/femsle/fnz031. [DOI] [PubMed] [Google Scholar]
- 60.Spanu T, Sanguinetti M, Tumbarello M, D'Inzeo T, Fiori B, Posteraro B, Santangelo R, Cauda R, Fadda G. 2006. Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates. J Clin Microbiol 44:3257–3262. doi: 10.1128/JCM.00433-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.CLSI. 2021. Performance standards for antimicrobial susceptibility testing, 30th ed CLSI supplement. CLSI/NCCLS M100-S30. Clinical and Laboratory Standards Institute. [Google Scholar]
- 62.Bioinformatics. B. FastQC a quality control tool for high throughput sequence data. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.
- 63.Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. 2012. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455–477. doi: 10.1089/cmb.2012.0021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Seemann T. 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30:2068–2069. doi: 10.1093/bioinformatics/btu153. [DOI] [PubMed] [Google Scholar]
- 65.Yoshida CE, Kruczkiewicz P, Laing CR, Lingohr EJ, Gannon VP, Nash JH, Taboada EN. 2016. The Salmonella In Silico typing resource (SISTR): an Open Web-accessible tool for rapidly typing and subtyping draft Salmonella genome assemblies. PLoS One 11:e0147101. doi: 10.1371/journal.pone.0147101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, Jelsbak L, Sicheritz-Ponten T, Ussery DW, Aarestrup FM, Lund O. 2012. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol 50:1355–1361. doi: 10.1128/JCM.06094-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Thomsen MC, Ahrenfeldt J, Cisneros JL, Jurtz V, Larsen MV, Hasman H, Aarestrup FM, Lund O. 2016. A bacterial analysis platform: an integrated system for analysing bacterial whole genome sequencing data for clinical diagnostics and surveillance. PLoS One 11:e0157718. doi: 10.1371/journal.pone.0157718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Junemann S, Sedlazeck FJ, Prior K, Albersmeier A, John U, Kalinowski J, Mellmann A, Goesmann A, von Haeseler A, Stoye J, Harmsen D. 2013. Updating benchtop sequencing performance comparison. Nat Biotechnol 31:294–296. doi: 10.1038/nbt.2522. [DOI] [PubMed] [Google Scholar]
- 69.Wick RR, Judd LM, Gorrie CL, Holt KE. 2017. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13:e1005595. doi: 10.1371/journal.pcbi.1005595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Treangen TJ, Ondov BD, Koren S, Phillippy AM. 2014. The Harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol 15:524. doi: 10.1186/s13059-014-0524-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Kumar S, Stecher G, Li M, Knyaz C, Tamura K. 2018. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 35:1547–1549. doi: 10.1093/molbev/msy096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Alikhan NF, Petty NK, Ben Zakour NL, Beatson SA. 2011. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 12:402. doi: 10.1186/1471-2164-12-402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Sullivan MJ, Petty NK, Beatson SA. 2011. Easyfig: a genome comparison visualizer. Bioinformatics 27:1009–1010. doi: 10.1093/bioinformatics/btr039. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplemental material. Download spectrum.02771-21-s001.xlsx, XLSX file, 4.8 MB (4.9MB, xlsx)
Supplemental material. Download spectrum.02771-21-s002.pdf, PDF file, 0.2 MB (163.7KB, pdf)





